Compare BHF & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHF | ICUI |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | United States |
| Employees | 1400 | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | N/A | 1995 |
| Metric | BHF | ICUI |
|---|---|---|
| Price | $65.68 | $157.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $57.71 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 441.6K | 278.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | N/A | ★ 1.20 |
| Revenue | N/A | ★ $2,231,262,000.00 |
| Revenue This Year | $27.10 | N/A |
| Revenue Next Year | $1.09 | $4.46 |
| P/E Ratio | ★ $4.34 | $135.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $43.16 | $107.02 |
| 52 Week High | $66.80 | $162.82 |
| Indicator | BHF | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 62.99 | 59.80 |
| Support Level | $63.87 | $146.59 |
| Resistance Level | $66.33 | $160.78 |
| Average True Range (ATR) | 0.78 | 5.34 |
| MACD | 0.06 | 0.17 |
| Stochastic Oscillator | 70.29 | 73.12 |
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.